Cargando…

Microbiome Profiling from Fecal Immunochemical Test Reveals Microbial Signatures with Potential for Colorectal Cancer Screening

SIMPLE SUMMARY: Colorectal cancer (CRC) is a global healthcare challenge that involves both genetic and environmental factors. Several pieces of evidence suggest that alterations of the gut microbiome can influence CRC development. In the present study we analyzed 16S rRNA sequencing data from fecal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khannous-Lleiffe, Olfat, Willis, Jesse R., Saus, Ester, Moreno, Victor, Castellví-Bel, Sergi, Gabaldón, Toni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817783/ https://www.ncbi.nlm.nih.gov/pubmed/36612118 http://dx.doi.org/10.3390/cancers15010120

Ejemplares similares

A Mouse Model Suggests That Heart Failure and Its Common Comorbidity Sleep Fragmentation Have No Synergistic Impacts on the Gut Microbiome
por: Khannous-Lleiffe, Olfat, et al.
Publicado: (2021)

Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential
por: Saus, Ester, et al.
Publicado: (2019)

Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma
por: Zhang, Yuhan, et al.
Publicado: (2021)

Reusing a prepaid health plan’s fecal immunochemical tests for microbiome associations with colorectal adenoma
por: Goedert, James J., et al.
Publicado: (2022)

Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening
por: Krigul, Kertu Liis, et al.
Publicado: (2021)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Discovery and Validation of Clinically Relevant Long Non-Coding RNAs in Colorectal Cancer
por: Snyder, Madison, et al.
Publicado: (2022)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
por: Malagón, Marta, et al.
Publicado: (2020)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Predicting the risk for colorectal cancer with personal characteristics and fecal immunochemical test
por: Li, Wen, et al.
Publicado: (2018)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems
por: Willis, Jesse R., et al.
Publicado: (2020)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Impact of temperature and humidity on performance of the fecal immunochemical test for advanced colorectal neoplasia
por: Park, Chan Hyuk, et al.
Publicado: (2019)

Performance of the Fecal Immunochemical Test in Patients With a Family History of Colorectal Cancer
por: Moosavi, Sarvee, et al.
Publicado: (2019)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

Positive fecal immunochemical test results are associated with non-colorectal cancer mortality
por: Jung, Yoon Suk, et al.
Publicado: (2022)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

Structural characterization of NORAD reveals a stabilizing role of spacers and two new repeat units
por: Chorostecki, Uciel, et al.
Publicado: (2021)

nextPARS: parallel probing of RNA structures in Illumina
por: Saus, Ester, et al.
Publicado: (2018)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Comment on “ Positive fecal immunochemical test results are associated with non-colorectal cancer mortality”
por: Park, Yong Eun
Publicado: (2023)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer
por: Saus, Ester, et al.
Publicado: (2016)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program
por: Rivero-Sánchez, Liseth, et al.
Publicado: (2018)

Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis
por: Kim, Dong Ju, et al.
Publicado: (2018)

Which Fecal Immunochemical Test Should I Choose?
por: Daly, Jeanette M., et al.
Publicado: (2017)

Profiling small RNAs in fecal immunochemical tests: is it possible?
por: Birkeland, Einar, et al.
Publicado: (2023)

The Transcriptional Aftermath in Two Independently Formed Hybrids of the Opportunistic Pathogen Candida orthopsilosis
por: Hovhannisyan, Hrant, et al.
Publicado: (2020)

Extreme diversification driven by parallel events of massive loss of heterozygosity in the hybrid lineage of Candida albicans
por: Mixão, Verónica, et al.
Publicado: (2020)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Timing and Risk Factors for a Positive Fecal Immunochemical Test in Subsequent Screening for Colorectal Neoplasms
por: Chiang, Tsung-Hsien, et al.
Publicado: (2015)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j7qefma0qkmv2fbk7g3b0vf9jj